Research on vaccines and immunization. Covers COVID and flu vaccines, outbreak response, long-lasting antibodies, and vaccination in vulnerable groups.
A recent study published in Archives of Pediatrics & Adolescent Medicine found no significant association between hepatitis B vaccination and the development of multiple sclerosis in children. The research involved 143 children who developed MS before age 16, with no increased risk of MS detected within three years of vaccination.
Vaccinating children under 2 with pneumococcal vaccine has been associated with decreased hospitalizations from pneumonia and reduced healthcare expenses. The vaccine is recommended for all children aged 2 months to 59 months, particularly those at increased risk for pneumococcal disease.
A new test vaccine against Japanese encephalitis virus has shown promising results, with a high seroconversion rate and good safety profile. The vaccine is considered at least as effective as the existing licensed vaccine, making it a potential candidate for use in travelers and children in endemic areas.
Researchers found that vaccinating half of a population can reduce cholera cases by 89% in unvaccinated individuals and 93% overall. Mass vaccination is a viable strategy to control endemic cholera outbreaks.
Researchers suggest that internationally licensed, killed whole-cell cholera vaccines may be highly effective in controlling endemic cholera when given via mass immunization. Vaccinating just 30% of the population every two years could achieve a 76% overall reduction rate.
A rotavirus vaccine has been shown to be highly effective in preventing gastroenteritis episodes in children, with high protection rates against all severities of the condition. The vaccine also significantly reduces the need for hospital treatment and medical attention related to gastroenteritis.
Researchers found seven cases of HIV-1 superinfection in 36 high-risk women over five years after initial infection. The study suggests that immune responses from natural HIV-1 infection may not be effective against re-infection, raising questions about the reliability of current vaccines.
A new research study from Oklahoma Medical Research Foundation demonstrates that immunization could blunt or prevent Alzheimer's disease by targeting the build-up of protein plaques. The vaccinated mice showed a significant reduction in plaque accumulation and improved cognitive performance compared to control mice.
Research published in Archives of Disease in Childhood found that severe chickenpox complications occur in hospitalized UK and Ireland children. Vaccination is key to preventing deaths and severe disease.
Researchers found that antibody responses to viruses like measles and mumps remain protective for several decades, even for life. This means people may not need booster shots as frequently as previously thought, potentially reducing unnecessary vaccinations.
Researchers at the University of Georgia Cancer Center have synthesized a carbohydrate-based vaccine that successfully triggered a strong immune response to cancer cells in mice. The vaccine has shown promise in creating an antibody response that can kill cultured epithelial cells and stimulating an immune response in healthy mice.
A survey of Quebec residents found that most young women would accept an HPV vaccine if it was offered for free, with 91% agreeing to vaccination. However, acceptance dropped sharply when the vaccine's cost was mentioned, highlighting concerns about access to healthcare services.
The American College of Physicians (ACP) has endorsed the 2007-08 adult immunization schedule, which recommends vaccination for varicella and zoster in adults. The CDC's adult immunization schedule aims to reduce vaccine-preventable deaths, with approximately 50,000 Americans dying each year from such diseases.
A new study from McGill University finds that the HPV screening test outperforms the traditional Pap test in detecting pre-cancerous lesions without false negatives. The HPV test achieved an accuracy of 94.6%, while the Pap test only reached 55.4% accuracy, making it a more reliable method for cervical cancer screening.
A new strain of Streptococcus pneumoniae bacteria has been detected that is resistant to all FDA-approved antibiotics and not covered by the pneumococcal 7-valent conjugate vaccine. This strain was found in nine cases, resulting in unsuccessful treatment with multiple antibiotics.
The report warns that inadequate pandemic planning, including poor on-the-ground administration and delivery of antivirals and vaccines, could threaten EU security. The survey found that few countries have defined plans for distribution of antivirals or specific guidance on vaccine storage and administration.
Scripps researchers created a dual-action compound that leapfrogs current efforts to develop an anthrax vaccine. The new agent protects against lethal toxin exposure after only one injection, with a potent immune response faster and stronger than any currently available vaccine.
The University of Georgia College of Veterinary Medicine has received a $1.18 million NIH grant to develop a less expensive and less invasive means of vaccinating humans and animals against rabies. The proposed vaccine will use a genetically modified form of the live virus, aiming to establish immunity with fewer doses and reduce costs.
A recent study published in The Journal of Pediatrics has found that administering a combination vaccine to infants does not compromise their immune response or safety. In fact, the study shows that combining three vaccines into one reduces the number of required vaccinations from five to three over six months.
The UK is considering vaccinating schoolgirls against the Human Papilloma Virus (HPV) to prevent cervical cancer. A pilot study led by the University of Manchester aims to assess the acceptability and feasibility of a three-dose vaccine, Cervarix.
A team of researchers at Stanford University School of Medicine has identified the most cost-effective way to fight treacherous hepatitis B by screening chronically infected individuals. Screening is more effective than vaccination in reducing mortality from hepatitis B, and vaccinating close contacts also provides significant benefits.
A new study found that irregular Pap smears and false negative tests were not the primary reasons for cervical cancer development. Instead, socio-economic disparities in screening access may be a major obstacle to eradicating the disease.
A study found that childhood vaccination for the rubella virus may have eliminated an inflammatory eye disease from the U.S.-born population. The vaccine was implemented in 1969, and subsequent reductions in Fuchs heterochromic iridocyclitis (FHI) cases were observed, especially among foreign-born patients.
Maternal and neonatal tetanus can be eliminated with effective action, including vaccination and proper care practices. However, sustaining elimination may require improvements in immunization and health services.
A recent study found that only 10% of teens receive annual preventive exams, leading to inadequate vaccination rates. The Centers for Disease Control and Prevention recommends three HPV shots within six months, but many teens are not seeing their doctors often enough.
A growing trend in oropharyngeal cancers is attributed to HPV infection, especially in younger males. This emerging epidemic warrants the exploration of HPV vaccine efficacy and safety in male populations.
A vaccine against anthrax has been developed using nanoparticles, which triggers a strong immune response and induces immunity on mucous membranes, providing protection after bioterror attacks. The new vaccine is easy to store and administer without needles, making it a valuable tool for health authorities.
A new study found that underinsured children are at risk of not getting needed vaccines due to lack of funding and restrictive policies. The authors suggest strategies to enhance immunization benefits for this vulnerable group of children.
Researchers have discovered a new vaccine strategy that effectively protects mice and guinea pigs from tuberculosis, targeting immune cells known as CD8+ T cells. The study suggests a potential breakthrough in developing a more effective vaccine for all individuals, including adolescents and adults.
The G8's $1.5 billion vaccine donation will mostly go to pharmaceutical firm profits rather than costs. Experts advocate for a more sustainable approach to maximize lives saved and benefit poor children.
Researchers argue that traditional cancer vaccine trial endpoints may be misguided, focusing instead on patient survival and response to subsequent treatments. The study suggests that vaccines can prime the immune system, keeping tumors in check and enhancing the effectiveness of subsequent therapies.
The Cervarix vaccine demonstrates effective protection against high-grade cervical pre-cancerous lesions caused by HPV types 16 and 18, and also provides additional protection against other strains of HPV that account for 10% of cervical cancers. The study involved over 18,000 women aged 15-25 years from around the world and found the ...
Researchers have made promising breakthroughs in understanding how antibodies can reduce the main hallmarks of Alzheimer's disease, including memory loss and ability to learn. The study suggests that antibodies could be used to prevent protein clusters from forming, which is believed to kill nerve cells.
Researchers identified common DNA variations that underlie susceptibility to fever after smallpox vaccination. Eight genetic alterations increased the likelihood of fever, while a few reduced it. The study raises the possibility that these genetic variations may also influence fever risk after other live-virus vaccines.
The Infectious Diseases Society of America has released a new blueprint to prevent tens of thousands of deaths and illnesses caused by vaccine-preventable diseases. The blueprint aims to improve vaccination rates among adults and adolescents, with a focus on increasing access to vaccines for underserved populations.
A new study published in The Journal of Infectious Diseases has identified eight gene clusters associated with altered susceptibility to fever after smallpox vaccination. These genetic variations are linked to the interleukin-1 (IL-1) gene complex and the interleukin-18 gene on chromosome 11.
Researchers at the University of Mainz have developed a novel approach to create antitumor vaccines by attaching tumor-associated glycopeptide antigens to a carrier protein via an immunocompatible thioether linkage. This method shows promise for inducing an immune response against cancer cells without irritating the immune system.
Infection with hepatitis B causes between 500,000 and 1.2 million deaths worldwide each year, with around 22,000 cases in Europe. A universal childhood vaccination policy is recommended to protect children before they are at risk of infection.
Researchers found that the polysaccharide vaccine can reduce meningitis cases by up to 72% in subsequent epidemics, making it an ideal tool for preventive vaccination strategy. A more cost-effective conjugated vaccine is also being developed to improve access to vaccines in African countries.
The quadrivalent HPV vaccine has been shown to be highly effective in preventing cervical cancer and precancerous lesions. The study found that the vaccine was 99% effective in women who had never had sex, but efficacy decreased to 44% when data from women who could have been exposed was included.
A quadrivalent human papillomavirus (HPV) vaccine has been shown to be highly effective in preventing high-grade vulval and vaginal lesions that can lead to cancers. The vaccine reduced the risk of all high-grade vulval and vaginal lesions by 49% in a population of sexually active young women.
A recent study published in the American Journal of Medical Genetics found no association between Rh immune globulin preserved with thimerosal and an increased risk of autism. Researchers investigated the exposure to thimerosal during pregnancies resulting in children diagnosed with autism and found no correlation.
A recent study published in American Journal of Medical Genetics Part A found no causal link between Rh immune globulin (preserved with thimerosal) exposure before birth and the development of autism. The study included over 200 mothers of children diagnosed with autism, revealing that Rh negative status and pregnancies with thimerosal...
Female ixodid ticks exhibit remarkable weight gain following mating, with some species increasing in size up to 100 times their original size. This phenomenon is linked to the tick's unique lifestyle and reproductive strategy, which involves prolonged feeding periods and specialized signals triggered by copulation.
A study published in Immunology Letters describes new ways of inducing immune responses through selective B cell priming, suggesting a potential approach to rational vaccine design. This discovery could have significant practical implications for vaccination development.
Researchers at Mayo Clinic have developed a breast cancer vaccine that successfully stimulated an anti-tumor T cell response in female mouse models, slowing or stopping the progression of breast cancer. The vaccine's effectiveness was achieved by combining synthetic peptides with a Toll-like receptor stimulant and anti-CD25 antibodies.
A rare case of hepatitis B virus transmission between two patients at a dentist's office has been documented, highlighting the need for meticulous infection control. Universal vaccination against HBV would likely have prevented both cases.
The Kirk A. Landon-AACR Prize for Basic Cancer Research recognizes Dr. Richard Kolodner for his work on DNA mismatch repair and its connection to human cancer. The Dorothy P. Landon-AACR Prize for Translational Cancer Research honors Douglas Lowy and John Schiller for their development of the human papillomavirus vaccine.
Dr. Russell is recognized for his contributions to understanding the protein antigens on Streptococcus mutans, a bacterium associated with dental caries. His work has led to the development of immunological interventions targeting this adhesin and improved mucosal immune response strategies.
Researchers found that flies' primitive immune systems can adapt and retain memory of an earlier infection, contradicting the long-held dogma. This discovery raises possibilities for developing human vaccines, especially for people with compromised immune systems.
Professor Ian Frazer, a renowned cancer vaccine innovator, has been awarded the prestigious Florey Medal for his groundbreaking work on cervical cancer prevention. The award recognizes the significant public health impact of his research, which aims to control cervical cancer rates in developing countries.
A national study estimates that approximately 1 in 4 U.S. females between 14 and 59 years old may have HPV infection, with the highest prevalence among younger women. The study also found a significant trend for increasing HPV prevalence with age, followed by a decline through 59 years.
Researchers at Harvard University have created a novel spraying method for delivering the most common tuberculosis (TB) vaccine, offering needle-free delivery and greater stability. This breakthrough could improve TB care and slow the spread of HIV/AIDS in developing countries.
A novel spray drying method has been developed to preserve and deliver the most common tuberculosis (TB) vaccine, promising greater stability at room temperature and use in needle-free delivery. This technique could provide a better approach for vaccination against TB and help prevent the spread of HIV/AIDS in developing countries.
Researchers warn that an immuno-contraception vaccine, which aims to control wildlife populations, is not fully effective and may manipulate natural reproduction in unpredictable ways. The vaccine also raises concerns about the potential for individuals who survive the vaccine to carry infectious diseases affecting other animals.
Researchers have discovered a protein, GAPDH, that allows group B streptococci to colonize and cause infection in newborns. The protein modulates the immune system, increasing the risk of invasive bacterial infection.
A study found that pneumococcal vaccination can prevent 262,000 child deaths annually. The vaccine's net cost of $838 million is considered cost-effective due to the significant reduction in child mortality.
Researchers used toll-like receptor agonists to stimulate an immune response against breast cancer tumors, preventing spontaneous growth and slowing tumor development. The vaccine was most effective when given prior to tumor appearance, extending survival but not curing the disease.
A study by Stanford researchers found that while 41% of autism research deals with brain and behavior, only 11% of media coverage addresses these topics. Instead, 48% focus on environmental causes, such as the childhood MMR vaccine, highlighting a stark disconnect between scientific research and public perception.
A pre-hatching prototype vaccine virus providing immunity against infectious bronchitis virus (IBV) has been developed by scientists at the Institute for Animal Health and Intervet UK. The vaccine can be delivered to chicks still in their egg using robotic 'vaccinators' and has shown protection rates of up to 100 percent.